Guided Therapeutics (GTHP) Shares Outstanding (2010 - 2025)

Guided Therapeutics' Shares Outstanding history runs 15 years deep, the most recent figure standing at $86.2 million for Q4 2025.

• In Q4 2025, Shares Outstanding rose 32.28% year-over-year to $86.2 million; the TTM figure through Dec 2025 stood at $86.2 million (up 32.28% YoY), while the FY2025 annual figure was $86.2 million, up 32.28% from the prior year.
• Shares Outstanding came in at $86.2 million for Q4 2025 at Guided Therapeutics, up from $83.6 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $86.2 million in Q4 2025 to a low of $2.0 in Q2 2024.
• A 5-year average of $28.2 million and a median of $17.8 million in 2021 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding plunged 99.99% in 2023 and soared 7897032.3% in 2025, its largest moves.
• Guided Therapeutics' Shares Outstanding stood at $2000.0 in 2021, then surged by 2429685.75% to $48.6 million in 2022, then climbed by 11.34% to $54.1 million in 2023, then rose by 20.38% to $65.1 million in 2024, then jumped by 32.28% to $86.2 million in 2025.
• According to Business Quant data, Shares Outstanding over the past three periods registered $86.2 million, $83.6 million, and $79.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison